how to ask my doctor for glp 1 What say when requesting GLP-1 options: guide to getting your prescription How to Talk About Weight-Loss

Sometimes the nausea causes people to stop taking these drugs in the first few weeks

GLP-1 has been heavily marketed, and skepticism is healthy

This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License

GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms

However, individuals with a BMI of 27 or higher who also have obesity-related health conditions like high blood pressure, high cholesterol, or diabetes may also qualify for these medications

*In the STEP 1 trial, participants received semaglutide 2.4 mg once weekly via subcutaneous injection, the FDA-approved formulation later marketed under the brand name Wegovy for chronic weight management in adults with obesity or overweight and at least one weight-related condition